ACADIA Pharmaceuticals, Inc. (ACAD)
21.31
-0.16
(-0.75%)
USD |
NASDAQ |
Mar 27, 09:49
ACADIA Pharmaceuticals Market Cap : 3.633B for March 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 31.31B |
| Madrigal Pharmaceuticals, Inc. | 11.63B |
| Marker Therapeutics, Inc. | 22.51M |
| Agilent Technologies, Inc. | 31.80B |
| Axsome Therapeutics, Inc. | 8.303B |
Market Cap Related Metrics
| PE Ratio | 9.312 |
| PS Ratio | 3.373 |
| PEG Ratio | 0.1364 |
| Price to Book Value | 2.960 |
| Price to Free Cash Flow | 572.92 |
| Price | 21.31 |
| Earnings Yield | 10.74% |
| PEGY Ratio | 0.1364 |
| Operating PE Ratio | 34.48 |
| Normalized PE Ratio | 9.312 |